Estrogen-dependent gallbladder carcinogenesis in LXRβ-/- female mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 33, 2010, Pages 14763-14768

  Gabbi, Chiara ^a,b   Kim, Hyun Jin ^b   Barros, Rodrigo ^b   Korach Andrè, Marion ^a   Warner, Margaret ^a,b   Gustafsson, Jan Åke ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b University of Houston   (United States)

Author keywords

Cancer; E cadherin; Hormone; Oxysterols; SMAD

Indexed keywords

ESTROGEN; LIVER X RECEPTOR BETA; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; CADHERIN; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DENSITY; CELL MEMBRANE; CELL NUCLEUS; CHOLECYSTITIS; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; FEMALE; GALLBLADDER; GALLBLADDER CANCER; GALLBLADDER CARCINOGENESIS; HISTOPATHOLOGY; IMMUNOREACTIVITY; MALE; METAPLASIA; MOUSE; NONHUMAN; OVARIECTOMY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AGE; ANIMAL; APOPTOSIS; BLOOD; C57BL MOUSE; CELL PROLIFERATION; GALLBLADDER TUMOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION;

ANIMALIA; MUS;

AGE FACTORS; ANIMALS; APOPTOSIS; CADHERINS; CELL PROLIFERATION; ESTROGENS; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; OVARIECTOMY; PHOSPHORYLATION; PRECANCEROUS CONDITIONS; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 77957047251     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1009483107     Document Type: Article

References (48)

1. Apfel R, et al. (1994) A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol 14:7025-7035.
2. Teboul M, et al. (1995) OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci USA 92:2096-2100.
3. Willy PJ, Mangelsdorf DJ (1997) Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev 11:289-298.
4. Janowski BA, et al. (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 96:266-271.
5. Peet DJ, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693-704.
6. Yu L, et al. (2005) Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280:8742-8747. (Pubitemid 40409561)
7. Repa JJ, et al. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14:2819-2830.
8. Joseph SB, et al. (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277:11019-11025.
9. Cao G, et al. (2003) Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 278:1131-1136.
10. Lo Sasso G, et al. (2010) Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes. Hepatology 51:1334-1344.
11. Chuu CP, et al. (2006) Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res 66:6482-6486.
12. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, Steffensen KR (2009) The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30:575-579.
13. Wente W, Brenner MB, Zitzer H, Gromada J, Efanov AM (2007) Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells. Endocrinology 148:1843-1849.
14. Meng ZX, et al. (2009) Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 52:125-135.
15. Geyeregger R, et al. (2009) Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol 86:1039-1048.
16. Kim HJ, Andersson LC, Bouton D, Warner M, Gustafsson JA (2009) Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc Natl Acad Sci USA 106:558-563.
17. Gong H, et al. (2007) Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 21:1781-1790.
18. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6-29.
19. Lazcano-Ponce EC, et al. (2001) Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51:349-364.
20. Misra S, Chaturvedi A, Misra NC, Sharma ID (2003) Carcinoma of the gallbladder. Lancet Oncol 4:167-176.
21. Henson DE, Albores-Saavedra J, Corle D (1992) Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer 70:1493-1497.
22. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellöf L (1989) Gallstone growth, size, and risk of gallbladder cancer: An interracial study. Int J Epidemiol 18:50-54.
23. Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q (2009) Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2:CD004143.
24. Gallus S, et al. (2002) Post-menopausal hormonal therapy and gallbladder cancer risk. Int J Cancer 99:762-763.
25. Liu B, et al.; Million Women Study Collaborators (2008) Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. Br Med J 337:a386.
26. Roa I, et al. (1996) Preneoplastic lesions and gallbladder cancer: An estimate of the period required for progression. Gastroenterology 111:232-236.
27. Roa I, de Aretxabala X, Araya JC, Roa J (2006) Preneoplastic lesions in gallbladder cancer. J Surg Oncol 93:615-623.
28. Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4:695-706.
29. Kozuka S, Tsubone N, Yasui A, Hachisuka K (1982) Relation of adenoma to carcinoma in the gallbladder. Cancer 50:2226-2234.
30. Gabbi C, et al. (2008) Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression. Proc Natl Acad Sci USA 105:15052-15057.
31. Ivanov DB, Philippova MP, Tkachuk VA (2001) Structure and functions of classical cadherins. Biochemistry (Mosc) 66:1174-1186.
32. Németh Z, et al. (2009) Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers. Pathol Oncol Res 15:533-539.
33. Hirata K, et al. (2006) Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis. Oncology 71:102-110.
34. Berx G, Van Roy F (2001) The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3:289-293.
35. Hugh TJ, et al. (1999) Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 80:1046-1051.
36. Cano A, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76-83.
37. Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 64:7686-7689.
38. Uno S, et al. (2009) Suppression of beta-catenin signaling by liver X receptor ligands. Biochem Pharmacol 77:186-195.
39. Lee SK, et al. (2001) Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2. Mol Endocrinol 15:241-254.
40. Antonson P, et al. (2008) RAP250 is a coactivator in the transforming growth factor beta signaling pathway that interacts with Smad2 and Smad3. J Biol Chem 283:8995-9001.
41. Choi YL, et al. (2004) An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 52:591-601.
42. Mori M, Miyazaki K (2000) Factors affecting morphogenesis of rabbit gallbladder epithelial cells cultured in collagen gels. Cell Tissue Res 300:331-344.
43. Gohongi T, et al. (1999) Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor beta1. Nat Med 5:1203-1208.
44. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B (2008) Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 69:360-367.
45. Hahn SA, et al. (1998) Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58:1124-1126.
46. Dorjgochoo T, et al. (2009) Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer 124:2442-2449.
47. Schuster GU, et al. (2002) Accumulation of foam cells in liver X receptor-deficient mice. Circulation 106:1147-1153.
48. Alberti S, et al. (2001) Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107:565-573.